Home Myteka 4mg Tablet
Myteka 4mg Tablet — Montelukast for Pediatric Asthma & Allergic Rhinitis | Derma.pk Pakistan
Oflobid 400mg Tablet — Broad-Spectrum Ofloxacin Higher Dose Antibiotic | Derma.pk Pakistan
Myteka 4mg Tablet — Montelukast for Pediatric Asthma & Allergic Rhinitis | Derma.pk Pakistan
Oflobid 400mg Tablet — Broad-Spectrum Ofloxacin Higher Dose Antibiotic | Derma.pk Pakistan

Myteka 4mg Tablet

Myteka 4mg Tablet contains Montelukast Sodium 4mg, a leukotriene receptor antagonist for asthma prophylaxis and allergic rhinitis in children aged 2–5 years. It prevents wheezing, nighttime coughing, and airway inflammation with daily use. Prescription required; carries an FDA black box warning for neuropsychiatric events — monitor for mood or behavioural changes.

Sale price Rs. 324

Pay in 3 Installments of

Rs.

124

Availability: In stock SKU: DRM-37FT
Tags: Allergic rhinitis pediatric Asthma prophylaxis children Breathing and wheezing relief Kids asthma prevention medicine Leukotriene receptor antagonist Montelukast 4mg Pakistan Myteka 4mg Tablet Pediatric allergy tablet Prescription Medicine
Myteka 4mg Tablet — Montelukast for Pediatric Asthma & Allergic Rhinitis | Derma.pk Pakistan

Myteka 4mg Tablet

Rs. 324

Myteka 4mg Tablet (Montelukast)

Myteka 4mg Tablet contains Montelukast Sodium, a leukotriene receptor antagonist used for asthma prophylaxis and allergic rhinitis in children aged 2–5 years. It works by blocking leukotrienes — natural substances that cause airway inflammation, chest tightening, and mucus production — reducing the frequency and severity of asthma symptoms and seasonal allergy reactions.

⚠ Important Safety Warning (FDA Black Box)
Montelukast (Myteka) carries a black box warning for serious neuropsychiatric events including depression, suicidal thoughts or behaviour, agitation, aggression, nightmares, hallucinations, and behavioural changes. Discontinue immediately if any of these symptoms occur and consult a doctor. Weigh benefits against risks before starting, especially in patients with a history of psychiatric illness.

Myteka 4mg is a daily controller medicine — it is not a rescue inhaler and should not be used for sudden asthma attacks. Continue regular dosing as prescribed even when the child feels well.

Conditions Treated

  • Asthma prophylaxis in children aged 2–5 years
  • Seasonal and perennial allergic rhinitis relief
  • Exercise-induced bronchospasm prevention
  • Nighttime coughing and airway hypersensitivity

Important Precautions

  • Neuropsychiatric monitoring: Watch for mood or behavioural changes, sleep disturbances, or unusual reactions
  • Not for acute asthma attacks — a rescue bronchodilator must be available
  • Inform the doctor of any prior psychiatric history
  • Use only under medical supervision; prescription required

Derma.pk delivers authentic, pharmacist-verified medicines nationwide across Pakistan. Order via WhatsApp: +92-320-5999650 or email: sales@derma.pk.

Usage & Benefits
  • Asthma prophylaxis for children aged 2–5 years — reduces attack frequency
  • Relieves seasonal and perennial allergic rhinitis symptoms
  • Prevents exercise-induced bronchospasm
  • Reduces nighttime coughing and airway hypersensitivity
  • Blocks leukotriene-mediated airway inflammation and chest tightening
  • Daily controller medicine — maintains long-term asthma control
How To Use

Dosage (as directed by doctor): Children aged 2–5 years — one 4mg chewable tablet once daily in the evening. Can be taken with or without food. Do not use as a rescue medicine during acute asthma attacks — a bronchodilator inhaler must be used for sudden symptoms. Continue regularly even when child feels well. Do not discontinue without medical advice. Monitor for any neuropsychiatric symptoms and report immediately.

FAQs

What age group is Myteka 4mg for?

It is indicated for children aged 2 to 5 years for asthma prevention and allergic rhinitis under a doctor's supervision.

Can Myteka 4mg stop a sudden asthma attack?

No — it is a daily controller medicine only. Use a rescue inhaler (bronchodilator) for acute attacks.

What is the black box warning for Montelukast?

Montelukast carries an FDA black box warning for serious neuropsychiatric events including depression, suicidal ideation, agitation, nightmares, and behavioural changes. Discontinue immediately and consult a doctor if these occur.

How long does treatment continue?

Duration is determined by the prescribing doctor based on the child's response. Do not stop abruptly without medical advice.